Skip to main content

Rockefeller University

!
Phase III+: The University is open for expanded research operations; only authorized personnel will be admitted on campus. More info here.

Event Detail (Archived)

Targeted Therapeutics for Triple Negative Breast Cancer

  • This event already took place in February 2021
  • Webinar

Event Details

Type
Other Tri-Institutional Events
Speaker(s)
Debra Auguste, Ph.D., professor, department of chemical engineering, Northeastern University
Open to
Public
Host
Dr. Gabriela Chiosis
Contact
Virviane Myers
Phone
(646) 888-3713
Sponsor
Virviane Myers
(646) 888-3713
myersv@mskcc.org

Related News

Why male mosquitoes leave humans alone

Unlike their female counterparts, male mosquitoes have no desire to bite us. But the hardware for host-seeking is hidden in the male mosquito brain, locked behind a simple genetic switch. 

This fish is about to flip 

An elaborate set of zebrafish experiments is shining light on one of neuroscience’s greatest enigmas: How brains make decisions. By tracking neural activity, scientists can now predict a fish’s next move before it happens.

Rockefeller grants commercial license for the development of monoclonal antibodies for treatment of COVID-19

The treatment, a combination of two antibodies, has been shown highly capable of neutralizing SARS-CoV-2 in preclinical studies. Researchers hope it will give countries around the world, including developing countries, a way to control the rampant disease.

Related Events

| WEBINAR

In Search of the Cause of Death of Dr. Semmelweis: From Budapest to Vienna and Back Again

| WEBINAR

Probing the Epigenome for Therapeutic Opportunities

| WEBINAR

Single Cell Genomics

Calendar of Events & Lectures

Browse upcoming and past Events and Lectures by keyword, program, date and type

Contact

Virviane Myers